DermTech (DMTK) Tops Q2 EPS by 2c

DermTech (NASDAQ: DMTK) reported Q2 EPS of ($0.99), $0.02 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $4.82 million.

For earnings history and earnings-related data on DermTech (DMTK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c